JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 53 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,300,000 | +123.8% | 149,463 | +143.2% | 0.38% | +121.8% |
| Q1 2018 | $581,000 | +274.8% | 61,447 | +119.8% | 0.17% | +335.9% |
| Q3 2016 | $155,000 | -80.6% | 27,950 | -75.5% | 0.04% | -81.5% |
| Q2 2016 | $800,000 | +72.8% | 114,194 | +63.1% | 0.21% | +83.5% |
| Q1 2016 | $463,000 | -38.4% | 70,000 | -4.1% | 0.12% | -29.4% |
| Q4 2015 | $752,000 | -31.4% | 73,000 | -21.5% | 0.16% | -29.1% |
| Q3 2015 | $1,096,000 | -23.9% | 93,000 | -40.9% | 0.23% | -10.5% |
| Q2 2015 | $1,440,000 | – | 157,382 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
| Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
| EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
| PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
| TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
| Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
| Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |